Common Variants in Signaling Transcription-Factor-Binding Sites Drive Phenotypic Variability in Red Blood Cell Traits
ARTICLES https://doi.org/10.1038/s41588-020-00738-2 Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits Avik Choudhuri1,2,24, Eirini Trompouki 2,3,4,24, Brian J. Abraham 5,6,24, Leandro M. Colli7,8, Kian Hong Kock9,10, William Mallard 1,11, Min-Lee Yang12, Divya S. Vinjamur 13, Alireza Ghamari14, Audrey Sporrij1, Karen Hoi1, Barbara Hummel3, Sonja Boatman2, Victoria Chan1, Sierra Tseng1, Satish K. Nandakumar 13, Song Yang2, Asher Lichtig2, Michael Superdock 2, Seraj N. Grimes9,15, Teresa V. Bowman2,16, Yi Zhou2, Shinichiro Takahashi17, Roby Joehanes18,19, Alan B. Cantor14, Daniel E. Bauer 13, Santhi K. Ganesh12, John Rinn1,20, Paul S. Albert7, Martha L. Bulyk9,10,11,15,21, Stephen J. Chanock 7, Richard A. Young 5,22 and Leonard I. Zon 1,23 ✉ Genome-wide association studies identify genomic variants associated with human traits and diseases. Most trait-associated variants are located within cell-type-specific enhancers, but the molecular mechanisms governing phenotypic variation are less well understood. Here, we show that many enhancer variants associated with red blood cell (RBC) traits map to enhancers that are co-bound by lineage-specific master transcription factors (MTFs) and signaling transcription factors (STFs) responsive to extra- cellular signals. The majority of enhancer variants reside on STF and not MTF motifs, perturbing DNA binding by various STFs (BMP/TGF-β-directed SMADs or WNT-induced TCFs) and affecting target gene expression. Analyses of engineered human blood cells and expression quantitative trait loci verify that disrupted STF binding leads to altered gene expression.
[Show full text]